During the last decades, catechol-O-methyltransferase (COMT) has been implicated in several human diseases, including different neurodegenerative disorders such as schizophrenia and Parkinson’s Disease (PD) [3,4], estrogen-induced cancers [5,6,7], or cardiovascular diseases [8]. The gene discussed is COMT; the disease is cancer.